Health Headlines: A Global Perspective on Innovations and Challenges

Recent health news covers significant events like Pfizer's diversity program settlement, AstraZeneca's halted UK investment, and a New York physician's legal battle over prescribing abortion pills. Additionally, updates on HIV data scrubbing, Metsera's Nasdaq debut, and J&J's legal challenges highlight ongoing issues in the health sector.

In recent health developments, Pfizer has addressed legal accusations surrounding its diversity fellowship program. The lawsuit, initiated by conservative group Do No Harm, alleged discrimination against non-minority applicants. Consequently, Pfizer has revised the initiative to accept applicants on a non-discriminatory basis.

Meanwhile, AstraZeneca has opted to abandon a substantial UK investment due to reduced government support. Originally intended to expand a vaccine manufacturing site in Liverpool, the decision reflects broader tensions as Britain seeks economic growth amidst shifting political landscapes.

In legal news, a New York physician faces indictment in Louisiana for prescribing an abortion pill to a minor. Both the doctor and the teenager's mother have been charged, underscoring the ongoing national debate over reproductive rights.

(With inputs from agencies.)